Bluesky Facebook Reddit Email

Understanding IP frameworks shaping vaccine research and policy

11.15.25 | Bentham Science Publishers

Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

As the world continues to navigate public health emergencies and equitable access challenges, this book provides a comprehensive look at the legal, ethical, and policy frameworks that shape vaccine development. It explores the evolution of patent protection in vaccinology, the interplay between innovation and affordability, and the impact of international agreements on vaccine distribution and research collaboration.

Through global case studies and in-depth analyses, the book highlights the need for balanced IP systems that encourage scientific progress while ensuring public health equity. It serves as a valuable reference for researchers, policymakers, legal experts, and healthcare professionals working at the intersection of science, law, and public health.

Key Features:

Traces the historical and legal evolution of vaccine-related intellectual property

Analyzes global access and equity challenges in vaccine distribution

Explores IP dynamics during the COVID-19 pandemic

Examines real-world case studies across policy and industry contexts

Offers actionable recommendations for stakeholders and decision-makers

Learn more about this book here: http://bit.ly/4hrGlpd

For media inquiries, review copies, or interviews, please contact Bentham Science Publishers.

About the Editors

Dr. Sachin K. Jain

Dr. Jain is Professor and Principal at the Oriental College of Pharmacy & Research, Oriental University, Indore, India, with over 18 years of teaching experience. He has authored more than 12 books with leading publishers and published over 100 research papers in reputed journals. He is the recipient of several national and international awards recognizing his contributions to pharmaceutical research and education.

Dr. Ravikant Gupta

With extensive experience in the pharmaceutical industry and academia, Dr. Gupta has contributed over 25 research papers, authored eight books, and participated in more than 50 national and international conferences. His expertise spans pharmaceutical innovation, formulation development, and research policy.

Dr. Sudha Vengurlekar

Dr. Vengurlekar brings over 20 years of academic experience in pharmaceutical sciences, specializing in medicinal and computational chemistry, pharmacology, and analytical research. She is recognized for her strong academic leadership and research contributions in pharmacy education.

Dr. Nidhi Bais

An Associate Professor at the Oriental College of Pharmacy and Research, Dr. Bais holds a Ph.D. in Pharmaceutics from DAVV, Indore. With extensive academic and research experience, she has participated in numerous national and international conferences and has several publications to her credit.

Dr. Gajendra P. Choudhary

Dr. Choudhary is Professor and Head of the School of Pharmacy at DAVV, Indore. A respected researcher in phytochemistry and herbal medicine, he has completed multiple funded projects and published over 100 papers. His work focuses on phytopharmacology, natural product analysis, and herbal formulation development.

10.2174/97898152747691250101

Keywords

Article Information

Contact Information

Noman Akbar
Bentham Science Publishers
nomanakbar@benthamscience.net

How to Cite This Article

APA:
Bentham Science Publishers. (2025, November 15). Understanding IP frameworks shaping vaccine research and policy. Brightsurf News. https://www.brightsurf.com/news/1EO7EE5L/understanding-ip-frameworks-shaping-vaccine-research-and-policy.html
MLA:
"Understanding IP frameworks shaping vaccine research and policy." Brightsurf News, Nov. 15 2025, https://www.brightsurf.com/news/1EO7EE5L/understanding-ip-frameworks-shaping-vaccine-research-and-policy.html.